Higher levels of serum uric acid influences hepatic damage in patients with non-alcoholic fatty liver disease (NAFLD)

Revista Española De Enfermedades Digestivas : Organo Oficial De La Sociedad Española De Patología Digestiva
Conrado M Fernández RodríguezManuel Romero-Gómez

Abstract

recent evidence suggests a causal link between serum uric acid and the metabolic syndrome, diabetes mellitus, arterial hypertension, and renal and cardiac disease. Uric acid is an endogenous danger signal and activator of the inflammasome, and has been independently associated with an increased risk of cirrhosis. six hundred and thirty-four patients from the nation-wide HEPAMET registry with biopsy-proven NAFLD (53% NASH) were analyzed to determine whether hyperuricemia is related with advanced liver damage in patients with non-alcoholic fatty liver disease (NAFLD). Patients were divided into three groups according to the tertile levels of serum uric acid and gender. the cohort was composed of 50% females, with a mean age of 49 years (range 19-80). Patients in the top third of serum uric acid levels were older (p = 0.017); they had a higher body mass index (p < 0.01), arterial blood pressure (p = 0.05), triglyceridemia (p = 0.012), serum creatinine (p < 0.001) and total cholesterol (p = 0.016) and lower HDL-cholesterol (p = 0.004). According to the univariate analysis, the variables associated with patients in the top third were more advanced steatosis (p = 0.02), liver fibrosis (F2-F4 vs F0-1; p = 0.011), NASH (p = 0.002) and ...Continue Reading

References

Nov 1, 1977·The Journal of Clinical Investigation·M H GinsbergD J McCarty
Jan 1, 1992·Journal of Molecular Evolution·X W WuC T Caskey
Feb 24, 1973·British Medical Journal·A NichollsJ T Scott
Jan 1, 1994·The Journal of Clinical Endocrinology and Metabolism·H Vuorinen-Markkola, H Yki-Järvinen
Dec 2, 1999·Atherosclerosis·F J NietoR G Cutler
Apr 19, 2002·Molecular Biology and Evolution·Masako OdaNaoyuki Takahata
Aug 23, 2002·Journal of the American Society of Nephrology : JASN·Peter W De LeeuwUNKNOWN Systolic Hypertension in Europe (Syst-Eur) Trial Investigators
May 26, 2005·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·David E KleinerUNKNOWN Nonalcoholic Steatohepatitis Clinical Research Network
Oct 28, 2005·Journal of the American Society of Nephrology : JASN·Duk-Hee KangRichard J Johnson
Dec 20, 2005·Blood Purification·Takahiko NakagawaRichard J Johnson
Apr 13, 2007·American Journal of Physiology. Cell Physiology·Yuri Y SautinRichard J Johnson
Oct 24, 2008·The New England Journal of Medicine·Daniel I FeigRichard J Johnson
Aug 21, 2010·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Cheng-Fu XuYou-Ming Li
May 29, 2012·Journal of Hepatology·Gyongyi Szabo, Timea Csak
Feb 2, 2013·Current Opinion in Rheumatology·Changgui LiShun-Jen Chang
Jul 19, 2014·Digestive Diseases·Wajahat Zafar Mehal
Dec 26, 2015·European Journal of Internal Medicine·Mehmet KanbayRichard J Johnson
Mar 2, 2018·Clinical Journal of Gastroenterology·Yuya SekoYoshito Itoh
Jul 4, 2018·Nature Medicine·Scott L FriedmanArun J Sanyal

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Diseases: Risk Factors

Cardiovascular disease is a significant health concern. Risk factors include hypertension, obesity, dyslipidemia and smoking. Women who are postmenopausal are at an increased risk of heart disease. Here is the latest research for risk factors of cardiovascular disease.

Related Papers

Revista médica del Instituto Mexicano del Seguro Social
Ricardo Salas-FloresAlonso Echegollen-Guzmán
Liver International : Official Journal of the International Association for the Study of the Liver
Carmelo García-MonzónMaría Eugenia Miquilena-Colina
© 2022 Meta ULC. All rights reserved